drugset / Trial / NCT03174756

HYPOCHLOROUS ACID SUBSTANTIVITY AS ANTIPLAQUE AGENT (HOCl-SAP)

NCT03174756

Phase 2 Completed 75 enrolled Universidad El Bosque, Bogotá
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Hypochlorous acid (HOCl) in a non-antibiotic antimicrobial agent used in clinical medicine. Nevertheless, its antiplaque oral effect has not been evaluated. Chlorhexidine (CHX) is the gold standard as an antiplaque agent for its high substantivity in plaque and saliva. There are no published studies evaluating the substantivity of hypochlorous acid compared to CHX. Objective: To evaluate the efficacy of mouthwashes of HOCl in substantivity evaluated by reduction of bacterial viability in saliva during 7 hours compared to CHX rinses and a placebo.

Timeline

Start
2015-01-15
Primary completion
2016-11-15
Completion
2016-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 0.025 % Oral
Comparator Chlorhexidine Small molecule 0.12 % Oral
Comparator Chlorhexidine Small molecule 0.2 % Oral
Subject Hypochlorous acid Other / unclassified 0.025 % Oral
Subject Hypochlorous acid Other / unclassified 0.05 % Oral

Indications

No indication recorded.